Market Research Report
Veterinary/Animal Vaccines Market Analysis By Product (Attenuated Live, Inactivated, Subunit, DNA and Recombinant), By Animal Type (Companion Animal, Cattle, Poultry, Equine), And Segment Forecasts, 2014 - 2025
|Published by||Grand View Research, Inc.||Product code||600775|
|Published||Content info||100 Pages
Delivery time: 2-3 business days
|Veterinary/Animal Vaccines Market Analysis By Product (Attenuated Live, Inactivated, Subunit, DNA and Recombinant), By Animal Type (Companion Animal, Cattle, Poultry, Equine), And Segment Forecasts, 2014 - 2025|
|Published: December 4, 2017||Content info: 100 Pages||
The global veterinary vaccines market is expected to reach USD 12.6 billion by 2025, according to a new report by Grand View Research, Inc. Rise in the outbreak of livestock diseases, expanding livestock population and increasing zoonotic diseases are driving the market growth. Increasing awareness regarding commercially available vaccines is pushing the adoption globally. However, higher costs associated with storage is challenging the growth and restricting the entry of new players.
This market has emerged to be one of the profitable investment options seeking attention and investments from both government and non-government players. Rise in the number of pet owners and their shifting focus towards healthy animal practices are some other factors propelling the growth of the market. Government intervention in distribution channel on the other hand, is affecting the profitability of the veterinary vaccine manufacturers. The bulk purchase and supply of livestock vaccines by countries such as India and Alaska that have large livestock population are reducing the profit margins of the vaccine manufacturers' through bulk pricing.